Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2026 Earnings Call Transcript May 7, 2026
Iovance Biotherapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.19 EPS, expectations were $-0.19.
Operator: Good day, and thank you for standing by. Welcome to the Iovance Biotherapeutics first quarter 2026 financial results conference call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to...
